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Inactivating variants as well as a missense variant in the centrosomal CEP78 gene
have been identified in autosomal recessive cone-rod dystrophy with hearing loss
(CRDHL), a rare syndromic inherited retinal disease distinct from Usher syndrome.
Apart from this, a complex structural variant (SV) implicating CEP78 has been reported
in CRDHL. Here we aimed to expand the genetic architecture of typical CRDHL
by the identification of complex SVs of the CEP78 region and characterization of
their underlying mechanisms. Approaches used for the identification of the SVs are
shallow whole-genome sequencing (sWGS) combined with quantitative polymerase
chain reaction (PCR) and long-range PCR, or ExomeDepth analysis on whole-exome
sequencing (WES) data. Targeted or whole-genome nanopore long-read sequencing
(LRS) was used to delineate breakpoint junctions at the nucleotide level. For all SVs
cases, the effect of the SVs on CEP78 expression was assessed using quantitative
PCR on patient-derived RNA. Apart from two novel canonical CEP78 splice variants
and a frameshifting single-nucleotide variant (SNV), two SVs affecting CEP78 were
identified in three unrelated individuals with CRDHL: a heterozygous total gene deletion
of 235 kb and a partial gene deletion of 15 kb in a heterozygous and homozygous
state, respectively. Assessment of the molecular consequences of the SVs on patient’s
materials displayed a loss-of-function effect. Delineation and characterization of the
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15-kb deletion using targeted LRS revealed the previously described complex CEP78
SV, suggestive of a recurrent genomic rearrangement. A founder haplotype was
demonstrated for the latter SV in cases of Belgian and British origin, respectively. The
novel 235-kb deletion was delineated using whole-genome LRS. Breakpoint analysis
showed microhomology and pointed to a replication-based underlying mechanism.
Moreover, data mining of bulk and single-cell human and mouse transcriptional datasets,
together with CEP78 immunostaining on human retina, linked the CEP78 expression
domain with its phenotypic manifestations. Overall, this study supports that the CEP78
locus is prone to distinct SVs and that SV analysis should be considered in a genetic
workup of CRDHL. Finally, it demonstrated the power of sWGS and both targeted
and whole-genome LRS in identifying and characterizing complex SVs in patients with
ocular diseases.
Keywords: CEP78, inherited retinal disease, cone-rod dystrophy with hearing loss, long-read sequencing,
structural variants, single-cell gene expression analysis
INTRODUCTION
During the last years, next-generation sequencing (NGS)
techniques mostly relying on short-read sequencing (SRS) have
accelerated molecular diagnoses in individuals with inherited
retinal diseases (IRDs) (Jespersgaard et al., 2019). IRD is
characterized by a tremendous genetic heterogeneity with
variants identified in more than 270 genes [RetNet (Retinal
Information Network)1]. Different types of variants can give
rise to IRD, both single-nucleotide variants (SNVs) as well
as structural variants (SVs), of which copy number variants
(CNVs) have been most frequently reported (Khateb et al., 2016;
Ellingford et al., 2018; Van Schil et al., 2018; Daiger et al., 2019;
Zampaglione et al., 2020). The latter are estimated to contribute
to at least 7%–10% of pathogenic alleles in IRD (Khateb et al.,
2016; Ellingford et al., 2018; Daiger et al., 2019; Zampaglione
et al., 2020). Interestingly, genomic features such as gene size
have been shown to correlate with CNV occurrence in IRD genes
(Van Schil et al., 2018).
Structural variant detection based on standard molecular
karyotyping and on sequencing depth algorithms is capable of
detecting only large CNVs, such as deletions and duplications
greater than 50 kb in size, whereas cryptic SVs, such as smaller
CNVs, copy neutral, and complex rearrangements, may be
missed (Lindstrand et al., 2019). Nowadays, it is possible to
detect approximately 27,000 SVs (>50 bp) per human genome
only using a combination of technologies, where the majority
of these SVs is located in the non-coding part of the genome
and missed using exome-based approaches (Belkadi et al., 2015;
Chaisson et al., 2019; Mahmoud et al., 2019). Whole-genome
sequencing (WGS) proved to be particularly powerful to detect
SVs, variants in GC-rich regions, and variants in non-coding
regulatory regions (Nishiguchi et al., 2013; Ellingford et al., 2016;
Carss et al., 2017; de Bruijn et al., 2020). While predictions are
indicating that at least 48% of deletions and 83% of insertions are
routinely missed by short-read-calling algorithms (Eichler, 2019),
1https://sph.uth.edu/retnet
long-read sequencing (LRS) is particularly valuable for detecting
SVs, as the long reads provide the necessary context to call
and resolve SVs, regardless of their sequence composition
(De Coster and Van Broeckhoven, 2019).
One of the more recently identified disease genes that
contribute to the genetic heterogeneity of IRD is the centrosomal
gene CEP78 (MIM# 617110), in which several types of
variants, inactivating sequence variants as well as a unique
missense variant have been found in autosomal recessive cone-
rod dystrophy with hearing loss (CRDHL; MIM# 617236), a
recognizable phenotype distinct from Usher syndrome (Fu et al.,
2016; Namburi et al., 2016; Nikopoulos et al., 2016; Ascari
et al., 2020). Apart from CRDHL, sperm abnormalities causing
infertility have been reported in two unrelated affected males
(Ascari et al., 2020). Functional studies pointed to a loss-
of-function effect with decreased amounts of protein, normal
subcellular localization, and elongated primary cilia in patients’
cells (Namburi et al., 2016; Nikopoulos et al., 2016; Ascari et al.,
2020). Interestingly, a complex SV implicating CEP78 has been
reported in one individual with CRDHL, being a homozygous
deletion–inversion–deletion overlapping CEP78 (Sanchis-Juan
et al., 2018). CEP78 localizes to the mature centrioles (Brunk
et al., 2016), which are the main components of the centrosomes,
key microtubule-organizing hubs in eukaryotic cells, with the
mother centriole acting as the basal body during cilia formation
(Gönczy and Hatzopoulos, 2019). Centrioles duplicate once per
cell cycle, and irregularities in their structure, or number, are
associated with several diseases including cancer or ciliopathies
(Nigg and Raff, 2009; Gönczy, 2015).
Here, we report CEP78 SVs and SNVs in four unrelated
CRDHL families of Belgian, Danish, and Turkish origin.
Interestingly, two distinct SVs were identified in three of the
four CRDHL families using a combination of NGS technologies.
Targeted or whole-genome nanopore LRS was used to delineate
breakpoint junctions at the nucleotide level. For the smallest SV,
a founder effect was shown. Overall, this study supports that
the CEP78 locus is prone to distinct SVs and emphasizes the
importance of SV analysis in the genetic workup of CRDHL,
Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 April 2021 | Volume 9 | Article 664317
fcell-09-664317 April 15, 2021 Time: 19:16 # 3
Ascari et al. LRS for SVs in CEP78
leveraging the power of shallow whole-genome sequencing
(sWGS) and both targeted and whole-genome LRS. Furthermore,
data mining of bulk and single-cell (sc) transcriptional datasets,
in combination with CEP78 immunostaining, displayed a




This study followed the tenets of the Declaration of Helsinki, and
ethical approval was given by the local ethics committee
(Ghent University Hospital, EC UZG 2017/1540). All
individuals involved gave their informed consent prior to
inclusion in this study.
Phenotypic Evaluation
Affected individuals were subjected to ophthalmologic evaluation
including best-corrected visual acuity measurement, funduscopy,
visual field assessment, infrared and blue light reflectance and
autofluorescence imaging, spectral-domain optical coherence
tomography, and electroretinography, when possible. In
addition, an audiological assessment was performed before or
after the molecular diagnosis.
Whole-Exome Sequencing and Variant
Validation
Genomic DNA (gDNA) was extracted from leukocytes according
the manufacturer’s guidelines. Whole-exome sequencing (WES)
was performed using SureSelectXT Human All Exon V6
enrichment (Agilent Technologies) and HiSeq 3000 sequencing
(Illumina) (F1 and F4), or SureSelectXT Low Input Human
All Exon V7 kit (Agilent Technologies) and NovaSeq 6000
sequencing (Illumina) (F3). Reads were aligned to the human
hg38 reference genome with BWA (v0.7.15) (Li and Durbin,
2009). SNVs and small insertions and deletions were detected
with the GATK HaplotypeCaller (v3.82). The VCF (variant
call format) files were annotated with the Ensembl Variant
Effect Predictor (release 95) and the dbNSFP (v3.4a) and
dbscSNV (v1.1) databases. Variants were scored heterozygous
or homozygous and were assessed with our in-house variant
filtering and visualization tool. A selection of 272 and 275
RetNet genes was assessed, respectively (versions 3 and 4 of
the RetNet panel). Nucleotide numbering was done following
HGVS guidelines3 with nucleotide “A” of the ATG as “c.1.”
Classification of variants was based on the ACMG and ACGS
guidelines with adaptations (Richards et al., 2015; Nykamp
et al., 2017; Abou Tayoun et al., 2018; Ellard et al., 2019).
CNVs were assessed using ExomeDepth (Plagnol et al., 2012)
(v1.1.10) and Pindel (Ye et al., 2009). Pathogenic (likely) variants
were confirmed via Sanger sequencing. Sanger sequencing
was performed using an ABI 3730xl DNA Analyzer (Applied
2https://www.biorxiv.org/content/10.1101/201178v3
3http://www.hgvs.org
Biosystems) with the BigDye Terminator Cycle Sequencing Kit
(Applied Biosystems).
For F2, II:1 gene panel sequencing of 13 genes [ABHD12,
ADGRV1 (GPR98), CDH23, CIB2, CLRN1, DFNB31 (WHRN),
HARS1, MYO7A, PCDH15, PDZD7, USH1C, USH1G, and
USH2A] associated with Usher syndrome was performed using
a HaloPlex custom design created by use of Agilent SureDesign
and included exons and 50 bp of the intron at each intron–
exon boundary. The enrichment library from patient DNA
was sequenced on a MiSeq sequencer (Illumina). FASTQ files
were analyzed using SureCall v.3.0.1.4 (Agilent Technologies)
using default settings. Whole-exome trio sequencing was
performed for F2, II:1 and her parents. Library preparation
was done using the Ion AmpliSeq exome kit (Thermo
Fisher), and libraries were sequenced using the IonProton
system (Thermo Fisher). Base calling, read alignment, and
variant calling were performed using the Torrent Suite
including the Torrent Variant Caller (Thermo Fisher). VarSeq
(GoldenHelix) was used for annotation and filtering of the
variants. Confirmation of the identified CEP78 variant was
performed via Sanger sequencing using NM_001098802.2 as
reference sequence.
Shallow WGS
Shallow whole-genome sequencing was performed using the
Hiseq3000 (Illumina), starting from 200 ng of gDNA. For library
construction the NEXTflex Rapid DNA Sequencing kit (Bio
Scientific) was used. Pipetting steps were automated using a
Hamilton Star robot (Hamilton). Library concentrations were
measured by the Qubit High-Sensitivity kit (Thermo Fisher
Scientific), and equimolar concentrations were pooled before
sequencing. The minimal number of mapped reads was set at 50
million. Copy number analysis was performed with WisecondorX
and further visualized with the ViVar platform (Sante et al., 2014;
Raman et al., 2019).
Quantitative and Long-Range
Polymerase Chain Reaction for Deletion
Confirmation and Delineation
Copy number variants were confirmed by quantitative
polymerase chain reaction (qPCR), and primers were designed
in coding exons or intronic regions as previously described
(D’haene et al., 2010). Assays were prepared using SsoAdvanced
Universal SYBR Green Supermix (Bio-Rad Laboratories) and
run on LightCycler 480 System (Roche). Data were analyzed
with qbase+ software (Biogazelle). ZNF80 and GPR15 were used
as reference genes. Subsequent to iterative qPCRs (long-range),
PCR was performed to obtain junction deletion products using
Phusion High-Fidelity PCR kit (New England Biolabs) and
visualized on 1% UltraPure Agarose (Thermo Fisher Scientific)
gels. Primer design was done using Primer3Plus. Primers
sequences are listed in Supplementary Table 1.
Targeted LRS
Amplified (long-range) PCR product was quality checked using
DropSense (Trinean), Qubit (ThermoFisher), and Fragment
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Analyzer (Agilent), using DNF-492 Large Fragment analysis
kit (Agilent). A library was constructed according to the
Ligation sequencing protocol (SQK-LSK109, Oxford Nanopore
Technologies, ONT; GDE_9063_v109_revU_14Aug2019) with
minor adaptations. DNA repair and end-prep using ONT
consumables (SQK-LSK109) and NEBNext FFPE DNA repair
mix and NEBNext Ultra II End repair/dA tailing Module (M6630,
E7546 both from New England Biolabs) started with 100 fmol of
the PCR amplicon, with extended enzymatic incubation times,
30 min at 20◦C and 30 min at 65◦C. Repaired and end-
prepped amplicon was Ampure XP (Beckman Coulter) cleaned
up for increased adaptor ligation efficiency, using a ratio of 1:1
(vol/vol) and extended incubation (10 min on Hulamixer). After
bead cleanup, the pellet was eluted in 32 µL Nuclease Free
Water, of which 30 µL was used for adapter ligation. Adapter
ligation using SQK-LSK109, ONT, and NEBNext Quick Ligation
Module (E6056, New England Biolabs) was performed according
to the protocol with extension of the ligation incubation
to 30 min at room temperature. The ligation reaction was
cleaned up using Ampure XP (Beckman Coulter) in vol/vol
ratio of 0.4 with extended incubation (10 min on Hulamixer).
A purified pellet was eluted in 10 µL of MilliQ water with
the final yield of library calculated using concentration and
size information (F1, II:1 yield = 508.2 ng/72.6 fmol and F3,
II:1 yield = 462 ng/61 fmol). Ten fmol (64 ng for F1, II:1)
and 20 fmol (151.5 ng for F3, II:1) amount of the library
was loaded and sequenced on MinION using Flongle Flowcell
(both Oxford Nanopore Technologies) with, respectively, 85
(F1, II:1) and 47 (F3, II:1) number of pores sequencing after
loading of the library. Sequencing was complete in 24 h
and generated in total 1.08 Gb (F1, II:1) and 827.9 Mb (F3,
II:1) of data, equaling 172.75 K (F1, II:1) and 140.99 K (F3,
II:1) reads with an estimated N50 of 10.55 kb (F1, II:1) and
10.7 kb (F3, II:1).
Whole-Genome LRS
Extracted DNA was checked for concentration, purity, and
integrity using DropSense (Trinean), Qubit (ThermoFisher), and
Fragment Analyzer (Agilent), using 464 High Sensitivity Large
Fragment 50-Kb kit (Agilent). The sample was sheared using
Mega3 (Diagenode) to the final average size of the peak 21,015 bp
(smear analysis 25,230 bp). Short fragments were eliminated
using SRE XS (Circulomics). Sheared and size-selected DNA
sample was used in library prep following the protocol gDNA
by Ligation (SQK-LSK109, GDE_9063_v109_revU_14Aug2019,
Oxford Nanopore Technologies) with minor adaptations. DNA
repair and end-prep using ONT consumables (SQK-LSK109)
and NEBNext FFPE DNA repair mix and NEBNext Ultra
II End repair/dA tailing Module (M6630, E7546 both New
England Biolabs) started with 182 fmol of the PCR amplicon,
with extended enzymatic incubation times, 30 min at 20◦C
and 30 min at 65◦C. Repaired and end-prepped amplicon
was Ampure XP (Beckman Coulter) cleaned up for increased
adaptor ligation efficiency, using a ratio of 1:1 (vol/vol) and
extended incubation (10 min on Hulamixer). After bead cleanup,
the pellet was eluted in 63 µL nuclease-free water, of which
60 µL was used for adapter ligation. Adapter ligation using
SQK-LSK109, ONT, and NEBNext Quick Ligation Module
(E6056, New England Biolabs) was performed according to
the protocol with extension of the ligation incubation to
30 min at room temperature. The ligation reaction was cleaned
up using Ampure XP (Beckman Coulter) in vol/vol ratio
of 0.4 with extended incubation (10 min on Hulamixer).
A purified pellet was eluted in 40 µL of MilliQ water with
final yield of library calculated using concentration and size
information (yield = 1,627.4 ng/105.6 fmol). Thirty femtomoles
of the final library prep was loaded onto PromethION Flow
cells (Oxford Nanopore Technologies). In order to generate
enough data, the sample was loaded on three flow cells (FCs).
Runs started with 6,844 (FC1), 5,835 (FC2), and 6,314 (FC3)
sequenceable pores and ran for 72 h, generating in total
32.55 Gb (FC1), 36.18 Gb (FC2), and 40.99 Gb (FC3) of data,
equaling 2.12 M (FC1), 2.39 M (FC2), and 2.68 M (FC3) reads
with an estimated N50 of 27.86 kb (FC1), 28.76 kb (FC2),
and 28.96 kb (FC3).
Data Analysis LRS
Base calling of the Nanopore data was performed using the
Guppy base caller (v4.0.9 + 92ae093). Further analysis was
performed using a pipeline integrated in GenomeComb (0.101.0)
(Reumers et al., 2012). Reads were aligned to the hg38 genome
reference (Schneider et al., 2017) using minimap2 (2.17-r941)
(Li, 2018), and the resulting SAM file sorted and converted to
BAM using Samtools (1.10) (Li et al., 2009). SVs were called
using Sniffles (1.0.11) (Sedlazeck et al., 2018). The region of
interest was filtered out and scanned for well-supported SVs
using GenomeComb (Reumers et al., 2012).
Expression Analysis on Patient’s Material
and Splicing Assessment
For quantitative reverse transcription–PCR (RT-PCR), total
RNA was extracted from short-term cultured lymphocytes
or fibroblasts using MagCore according the manufacturer’s
guidelines. cDNA was synthesized with the iScript cDNA
Synthesis Kit (Bio-Rad Laboratories). For each cDNA sample,
assays were prepared using SsoAdvanced Universal SYBR Green
Supermix (Bio-Rad Laboratories) and run on LightCycler
480 System (Roche). Data were analyzed with qbase + and
normalized to the YWHAZ and HMBS or SDHA genes. Primers
were designed using Primer3plus, and sequences are listed in
Supplementary Table 1. For non-quantitative RT-PCR, cDNA
was synthesized using SuperScript IV Reverse Transcriptase kit
(Thermo Fisher) and underwent standard PCR, loaded on 2%
UltraPure Agarose gel, and Sanger sequenced.
Haplotype Analysis
In total, 18 single-nucleotide polymorphisms (SNPs) (dbSNP,
build 151) were selected for haplotype reconstruction in the
upstream and downstream areas flanking CEP78. SNPs were
Sanger sequenced according to the standard procedures (see
above). PCR primers were designed with Primer3Plus, and
sequences can be found in Supplementary Table 2.
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CEP78 Expression in Mouse and Human
Retina and Inner Ear
Data Mining in Single-Cell Retinal and Cochlear
Transcriptional Datasets
Human adult retinal and murine P1 cochlear sc transcriptional
datasets were mined for evaluating CEP78 expression at
the sc level. Expression matrices derived from pooling
three donor neural retinal (Cowan et al., 2020) and four
cochlear samples (Kolla et al., 2020) were retrieved and
processed separately using SCANPY (v1.4.6) (Wolf et al.,
2018). Preprocessing and quality control were conducted to
remove outlier cells. Briefly, we considered only genes with
counts of at least three cells and filtered out cells that had
unique feature counts <200 or >2,500 and/or that expressed
>5% mitochondrial counts. The data were then total-count
normalized, logarithmized, filtered for highly variable features,
and scaled to unit variance. After quality control preprocessing,
a total of 19,768 retinal and 11,332 cochlear cells were kept
for subsequent dimensionality reduction, embedding, and
clustering. Markers associated with major neural retina and
cochlear cell populations were used to assess CEP78 expression
at the sc level.
Data Mining in Bulk Retinal and Cochlear
Transcriptional Datasets
Retina| Expression levels by transcripts per million (TPMs)
were retrieved from postmortem retina samples characterized
in Ratnapriya et al. (2019). From 453 samples that passed
quality control, we only considered donor retinas that showed
no age-related macular degeneration progression (n = 102)
to avoid confounding variables in downstream analyses. To
remove potential noise, 20% of genes with the lowest mean
expression across all samples were filtered out. TPM values
were then filtered for a set of candidate genes, which included
all genes reported to cause IRD (RetNet) and ciliary genes
(SCGSv1) (van Dam et al., 2013). A total of 519 genes were
eventually considered. Before evaluating correlations in the
expression of the candidate genes, the set was subjected to a
variance-stabilizing transformation to correct for mean-variance
dependency (Zwiener et al., 2014). We then examined the
expression of CEP78 and several ciliary genes listed in the
top 10 of the Human Gene Connectome (HGC) (Itan et al.,
2013) (SCLT1, MKS1, CEP57, CEP76, CEP135, CEP152, CEP63,
CEP164, OFD1, and CEP250). Spearman correlations were
computed along with pairwise p values adjusted for multiple
comparisons (Holm method). A correlogram was then generated
for visualization.
Cochlea| We retrieved paired-end FASTQ files (GSE111348)
derived from adult (P28-P32) mouse inner (IHC) and outer
(OHC) cochlear hair cells (∼1,000 cells per sample; n = 4
and 6 for IHC and OHC, respectively) (Li et al., 2018).
Transcripts were quantified through pseudoalignment by
Kallisto (v.0.46.1), for which default parameters were used
for both index build and transcript quantification (Bray
et al., 2016). Additionally, data generated by Schrauwen
et al. (2016) were used to retrieve expression values of
CEP78 in adult human cochlea and components of the
vestibular labyrinth.
CEP78 Immunostaining on Human Retina
Human retina used for immunohistochemistry was fixed in
10% neutral buffered formaldehyde and embedded in paraffin.
Staining for CEP78 was performed on 3-µm-thick sections
using an automatic immunostainer (BenchMark Ultra, Ventana
Medical Systems, Tucson, AZ, United States). The rabbit
polyclonal antibody anti-CEP78 (1:100; LN2004459, LabNed)
was used, and visualization was achieved with the OptiView
Amplification Kit (Ventana Medical Systems). Heat-induced
epitope retrieval was performed using Cell Conditioning 2
(Ventana Medical Systems).
RESULTS
The CRDHL families included in this study are of Belgian (F1
and F3), Danish (F2), and Turkish origin (F4). Consanguinity was
reported for F4. Pedigrees are represented in Figure 1.
CNV Analysis on WES Data, sWGS,
Long-Range PCR, and Targeted
LRS in F1
For F1, II:1 CNV analysis on WES data using ExomeDepth
revealed a potential homozygous deletion overlapping CEP78
[initial coordinates (hg38) chr9: g.78236351–78243636].
Subsequent sWGS confirmed the homozygous deletion spanning
exons 1–5 of CEP78 [new coordinates (hg38) chr9:g.78230001–
78245000], covering a region of 15–20 kb. The sWGS output
is available in Supplementary Table 3. The deletion could be
refined up to ∼12 kb using iterative qPCRs, and a junction
product could be obtained via long-range PCR (Supplementary
Figure 1). Targeted LRS on the long-range PCR amplicon allowed
final delineation, identifying a complex deletion–inversion–
deletion (Figure 2). The left breakpoint is located at (hg38)
chr9:78228782, whereas the right breakpoint at chr9:78244762.
The inverted segment spans chr9:78234546–78234844 [nearby
an L1ME3Cz repetitive element (chr9:78234521–78234902)].
The SV overlaps with the one previously described in a British
patient by Sanchis-Juan et al. (2018), delineated using microarray
and Sanger sequencing (Sanchis-Juan et al., 2018). A smaller
deletion, overlapping exons 2 and 3 in CEP78, is reported in
gnomAD SV (DEL_9_103019; gnomAD SVs v2.1). Segregation
analysis was performed via qPCR and confirmed both parents
as heterozygous carriers of the deletion. Expression analysis
of CEP78 mRNA on available lymphocytes (F1, II:1) and three
controls showed complete loss of CEP78 expression due to the
homozygous deletion (Supplementary Figure 2).
Segregation Analysis, sWGS, and
Whole-Genome LRS in F2
For F2, II:1, initial targeted gene panel sequencing was negative,
as it was carried out before the CEP78 gene had been associated
with CRDHL. Thus, trio WES was performed for the proband
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FIGURE 1 | Pedigrees segregating the CEP78 structural and sequence variants and haplotype reconstruction for the shared SV. (A) F1, II:1 is homozygous for a
complex deletion–inversion–deletion involving exons 1–5 of CEP78. F2, II:1 is compound heterozygous for a deletion of 235 kb overlapping CEP78 and PSAT1 and
for splice site variant c.1209-2A>C. F3, II:1 is compound heterozygous for the same deletion–inversion–deletion of F1, II:1 and the c.1449dup variant in CEP78. F4,
II:1 is homozygous for splice site variant c.1208+2T>A. Extended F4 pedigree available in Supplementary Clinical Data 2. (B) Genotyping of 18 flanking
single-nucleotide polymorphisms (SNPs) revealed a common haplotype of 1.9 Mb, between the individuals carrying the deletion–inversion–deletion [F1, F3 and the
case originally described by Sanchis-Juan et al. (2018)]. Extended version available in Supplementary Table 5. Abbreviations: Del, deletion (or
deletion–inversion–deletion); wt, wild type.
and revealed a novel heterozygous splice variant c.1209-2A>C
p.(?) (NM_001098802.2) in CEP78. The c.1209-2A>C variant
in CEP78 was confirmed via Sanger sequencing, where the
proband appeared homozygous, the father heterozygous and
the mother wild-type (Supplementary Figure 3). No additional
family members have been tested. The splice variant is located
in the acceptor splice site of intron 9, reported in dbSNP
(rs778035330) with a frequency of 0.00002628 (gnomAD), and
predictions suggest a skip of exon 10. It is predicted to disrupt
the consensus splice site and likely results in an absent or
disrupted protein product and loss of function. Subsequent
RT-PCR confirmed the skip of exon 10 (Supplementary
Figure 3). Population frequencies and in silico predictions of the
CEP78 splice variant are listed in Supplementary Table 4 and
Supplementary Figure 4. To our knowledge, this variant has not
been reported in literature, but is reported as likely pathogenic in
one case in ClinVar (ID 851351). Segregation analysis suggested
a heterozygous genomic deletion of the CEP78 region in F2, II:1,
in trans with the splice variant. The heterozygous deletion was
confirmed by sWGS, showing an interval of 225–240 kb spanning
the entire CEP78 and PSAT1 genes (chr9: g.78105001–78330000).
The sWGS output is available in Supplementary Table 3. The
final delineation was obtained via whole-genome LRS allowing
the identification of a heterozygous (13 reference sequence reads,
21 deletion reads) deletion spanning the region chr9:78096930–
78331887 and covering 235 kb (Figure 2). Breakpoint junction
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FIGURE 2 | sWGS output and integrative genomics viewer (IGV) view of the structural variants (SVs) detected via long-read sequencing (LRS) in F1 and F2.
(A) sWGS in F1, II:1 revealed a homozygous deletion of the region spanning exons 1–5 of CEP78 (top). Subsequent delineation of the SV via targeted LRS of the
junction product identified a complex deletion–inversion–deletion (bottom). The left breakpoint is located at (hg38) chr9:78228782, whereas the right breakpoint is
located at chr9:78244762. The inverted segment spans chr9:78234546–78234844 [nearby an L1ME3Cz repetitive element (chr9:78234521–78234902)]. The SV
overlaps with a previously described SV affecting CEP78 (Sanchis-Juan et al., 2018). (B) sWGS in F2, II:1 identified a heterozygous deletion spanning the entire
CEP78 and PSAT1 genes (top). Final delineation was obtained via whole-genome LRS, coordinates are crossing chr9: 78096930–78331887 and cover 235 kb
(bottom).
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FIGURE 3 | Deletion coverage plots and IGV view of the complex SV detected via targeted LRS in F3, II:1. (A) ExomeDepth coverage plots for homozygous deletion
(F1, II:1, top) and heterozygous deletion (F3, II:1, middle) compared to control (bottom). Coverage suggested for F3, II:1 the same deletion described for F1, II:1 but
in heterozygous state. (B) Delineation of the SV via targeted LRS of the junction product obtained in F3, II:1 identified the same complex deletion–inversion–deletion
found previously in F1, II:1.
analysis highlighted microhomology (Supplementary Figure 5).
Expression analysis of CEP78 mRNA on available fibroblasts (F2,
II:1) and two controls showed loss of CEP78 expression due to the
CEP78 genotype (Supplementary Figure 2).
CNV Analysis on WES Data, Long-Range
PCR, and Targeted LRS in F3
For F3, II:1 CNV analysis on WES data using ExomeDepth
revealed a heterozygous deletion overlapping CEP78 with the
same coordinates of the deletion in F1, II:1 (Figure 3) in
combination with c.1449dup [p.(Arg484Thrfs∗4)]. The latter is
a novel 1-bp duplication in exon 12, creating a frameshift starting
at codon Arg484. The new reading frame ends in a stop codon
at position 4 (Supplementary Table 4). Segregation analysis
confirmed the presence of c.1449dup on the maternal allele,
while the deletion has paternal origin (Supplementary Figure 6).
A junction product could be obtained via long-range PCR using
the same primers used for F1, II:1. Targeted LRS on the long-
range PCR amplicon allowed a final delineation, identifying once
more the same complex deletion–inversion–deletion as found
in F1, II:1 (Figure 3). Expression analysis of CEP78 mRNA on
available lymphocytes (F3 I:1, I:2, and II:1) and three controls
showed extremely reduced CEP78 expression due to the variants
in the index case (Supplementary Figure 2).
Haplotype Reconstruction for Recurrent
Deletion–Inversion–Deletion of CEP78
Identified in F1 and F3
The same deletion–inversion–deletion, originally described by
Sanchis-Juan et al. (2018), has been identified here in F1
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FIGURE 4 | Representative ophthalmological pictures of individuals from F1 and F3 carrying CEP78 structural variants. (I) F1, II:1. (I-A) Color fundus photograph of
LE with normal optic disk, minimal narrowing of retinal arterioles, RPE mottling around the temporal vascular arcades, no bone spiculae. (I-B) BAF of the RE with
hyperautofluorescent ring surrounding the fovea and granular hypo-autofluorescence around the temporal vascular arcades. (I-C) Spectral-domain OCT of the LE
depicting loss of perifoveal photoreceptor layer and better foveal quality with loss, however, of integrity of photoreceptor outer segments. (II) F3, II:1. (II-A) Eye
fundus of the left eye with perifoveal fine, granular, yellowish material upon close inspection. Normal aspect of optic disk, peripheral retina, and retinal vessels. (II-B)
Close-up of the macular area, demonstrating the fine, granular, yellowish material encircling the fovea. (II-C) BAF of the LE without obvious abnormalities. (II-D)
Fluorescein angiography of the LE with normal fluorescence. (II-E) Near-infrared imaging of the LE (hyperintense circular area is an artifact). (II-F) Spectral-domain
OCT of the LE, revealing a mottled aspect of the ellipsoid zone and subfoveal collection of fluffy material. Enlarged and flat foveal depression. BAF, blue-light
autofluorescence imaging; OCT, spectral-domain optical coherence tomography; RE, right eye; LE, left eye; RPE, retinal pigment epithelium.
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(homozygous) and F3 (heterozygous, with paternal inheritance);
therefore, haplotype reconstruction using genotyping of 18 SNPs
was performed in the proband of F1 (II:1) and in the proband and
parents of F3 (II:1, I:1, and I:2). In addition, the haplotype of the
homozygous CEP78 SV reported by Sanchis-Juan et al. (2018),
was reconstructed here on the basis of available WGS data.
A common shared haplotype of at least 1.9 Mb was identified
(Supplementary Table 5).
Phenotypic Expression of CEP78
Disease Caused by SVs and SNVs
In F4, II:1 WES filtering revealed a novel homozygous splice
variant c.1208+2T>A [p.(?)] (NM_001098802.2), located in
the donor splice site of intron 9 and predicted to cause
skipping of exon 9. The variant involves the same intron
as the one affected by c.1209-2A>C in F2, II:1 and is
not reported in gnomAD. Segregation analysis in two of
the obligate carrier children confirmed they are heterozygous
carriers. Population frequencies, in silico predictions, and variant
classification according to ACMG and ACGS criteria are listed
in Supplementary Table 4 and Supplementary Figure 4. All
patients included received an initial (F1, F2, and F3) or post hoc,
genotype-driven (F4) clinical diagnosis compatible with CRDHL.
In agreement with previous studies, the IRD phenotype displays
a more pronounced cone dysfunction at the onset. The age at
onset of the IRD ranged from the second to third decade and, of
the hearing loss, from congenital to the first decade of life. More
detailed clinical features are provided in Figure 4, Table 1, and
Supplementary Clinical Data 1, 2. Affected individuals from F1
to F3 are females, whereas the affected individual from F4 is a
male, without signs of subfertility/infertility. Apart from CRDHL,
no additional clinical features were reported except for a balance
disorder in F1. Overall, no genotype–phenotype correlation could
be observed for the IRD phenotype in probands with biallelic
CEP78 SVs, SNVs, or a combination of both.
CEP78 Expression in Human and Mouse
Tissues Affected in CRDHL
In line with the main systems affected in CRDHL, i.e., neural
retina and the inner ear, we examined CEP78 expression in sc
transcriptional datasets of human neural retina together with
mouse and human cochlear or inner ear cells. This showed that
CEP78 is predominantly expressed in cone photoreceptor and
in hair cell clusters, respectively (Figure 5 and Supplementary
Figures 7, 8). Next, the expression patterns of CEP78 and
other ciliary genes listed in the top 10 of the HGC (Itan
et al., 2013), SCLT1, MKS1, CEP57, CEP76, CEP135, CEP152,
CEP63, CEP164, OFD1, and CEP250, in human adult bulk
retinal transcriptional datasets were assessed for coordinated
correlation, reasoning that this could offer insight into possible
regulatory interactions. Interestingly, a matrix correlation plot
(Supplementary Figure 9) showed CEP78 expression to be
correlated with SCLT1 (ρ = 0.63, p < 0.001) and to be
anticorrelated with CEP250 (ρ = −0.53, p = 0.0007), both of
them already associated with IRD (Khateb et al., 2014; Tonda
et al., 2016; Kubota et al., 2018). Immunohistochemistry analysis
of human retina shows predominant cytoplasmic expression of
CEP78 in both cones and rods, with strong staining at the base of
the inner segments, concordant with previous findings (Figure 5;
Namburi et al., 2016; Nikopoulos et al., 2016).
DISCUSSION
In this study, we focused on CEP78-associated IRD, of which
several studies have linked CEP78 variants with a presumed
loss-of-function effect to CRDHL. Interestingly, a homozygous
complex SV affecting CEP78, i.e., a deletion–inversion–deletion,
was recently described in a case of CRDHL (Sanchis-Juan et al.,
2018). We assessed the role of SVs in CRDHL cases and found
two distinct SVs affecting the CEP78 region, emphasizing their
role in CEP78 disease. We showed the efficacy of CNV analysis
of WES data to identify subtle CNVs; more specifically, we
identified a deletion spanning exons 1–5 of CEP78, in both
homozygous and heterozygous states, leading to loss of function.
Furthermore, we showed the power of combined sWGS, qPCR,
and targeted or whole-genome LRS to delineate and characterize
SVs at the nucleotide level. This approach revealed a complex
15-kb deletion–inversion–deletion, which proved to be the same
as the previously reported CEP78 SV that was found and
characterized by combined molecular karyotyping and Sanger
sequencing. As this deletion was identified in the two families
of Belgian origin and in a previously published case of a British
patient, haplotype reconstruction was performed and suggested
a founder effect. Apart from this, a distinct larger SV, being
a 235-kb heterozygous deletion, was identified using molecular
karyotyping and characterized using whole-genome LRS. This
deletion encompasses the CEP78 and PSAT1 (MIM #610936)
genes, the latter of which has so far only been implicated in
recessive phosphoserine aminotransferase deficiency (MIM #
610992) and Neu-Laxova syndrome 2 (MIM # 616038) (Hart
et al., 2007; Acuna-Hidalgo et al., 2014). Overall, for all cases
with CEP78 SVs identified by us, loss of CEP78 expression
was confirmed on patient-derived material. The latter is in line
with the molecular effects of the previously reported CEP78
sequence variants.
Sanchis-Juan et al. (2018) reported that the sequences
surrounding all the breakpoints of the described SV in
CEP78 present high similarity to long interspersed nuclear
elements (LINEs). It was hypothesized that repetitive elements
enable replication-based SV formation, providing the necessary
microhomology islands or increasing the vulnerability of the
region to the formation of secondary DNA structures, which can
lead to replication fork collapse (Sanchis-Juan et al., 2018). We
performed a similar extensive in silico analysis of all breakpoints
and junctions of the SVs identified in this study (Supplementary
Figures 5, 10 and Supplementary Tables 6, 7). Interestingly,
all breakpoint junctions, including the 235-kb CEP78-PSAT1
deletion, showed microhomology, supporting repetitive element-
mediated replication-based SV formation underlying CEP78
SVs/complex SVs. Our findings underscore that SVs contribute
to the genetic diversity of the human genome and are of high
relevance for the molecular pathogenesis of rare diseases. Very




















TABLE 1 | Overview of clinical findings in CEP78-associated CRDHL.








F1 II:1 45 y/F Belgian 22 y 0.1/0.1 Small central island
























































































































BAF, blue-light autofluorescence imaging; BCVA, best-corrected visual acuity; CF, counting fingers; ERG, full-field flash electroretinography; F, female; HM, hand movements; M, male; NA, not available; OCT, spectral-
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FIGURE 5 | Single-cell transcriptional data in human retina and immunohistochemistry of CEP78 in adult human retina. (A) Violin plot for visualization of scaled and
corrected expression of CEP78 in 19,768 human neural retinal cells. Cells belonging to the cone cell population exhibit the highest expression. (B) Immunostaining of
the CEP78 protein is visible in light brown. Light microscopy at 200 × (top) and 400 × (bottom). Predominant cytoplasmic expression of CEP78 can be seen in both
cone and rod photoreceptors with strong staining at the base of the inner segments. Antibody: LN2004459 (1:100, rabbit, LabNed). GCL, ganglion cell layer; IPL,
inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OLM, outer limiting membrane; IS, inner segments; OS, outer
segments.
recently, SVs were mapped and characterized in 17,795 deeply
sequenced human genomes (Abel et al., 2020). It is estimated
that SVs account for 17.2% of rare alleles genome-wide and that
approximately 90% of such SVs are non-coding deletions. The
number of complex SVs as a cause of genetic diseases is emerging.
This is illustrated by de novo interspersed repeat insertions found
in 124 cases with a genetic disease, 76 of which are caused by Alu
short interspersed elements (SINEs), and 30 can be attributed to
LINE-1 insertions (Payer et al., 2017). Two remarkable examples
of complex SVs as a cause of IRD are SVA retrotransposon
insertions in MFSD8- and BBS1-associated disease, of which
the first SV served as a target for antisense oligonucleotide
treatment, and the second appears to be a frequent cause of
Bardet–Biedl syndrome (Kim et al., 2019; Delvallée et al., 2020).
Another recent example is the identification of 33 pathogenic SVs
in a cohort of 722 patients with autosomal dominant retinitis
pigmentosa (adRP). Indeed, eight distinct complex non-coding
SVs were found as the underlying mechanism of RP17-linked
adRP in 22 affected families with >300 affected individuals,
clearly emphasizing the importance of the non-coding genome
as target for SVs in IRD (de Bruijn et al., 2020).
Given a high contribution of CNVs to ∼7%–10% of the
pathogenic alleles in IRD, the fact that the majority of the SVs
in our genome are non-coding and the emerging number of
non-coding or complex SVs causing IRD (Abel et al., 2020;
Zampaglione et al., 2020), it can be expected that SVs represent
an important part of missing heritability of IRD. Hence, there
is a need to assess the impact and frequency of SVs in IRD
cohorts more systematically. Here, we showed how CNV calling
on WES data, sWGS, and targeted or whole-genome LRS led to
a confirmed molecular diagnosis in CEP78-associated IRD cases.
CNV assessment using NGS-based algorithms has been already
described as a reliable method to enhance the diagnostic rate of
IRD (Khateb et al., 2016; Ellingford et al., 2018). Furthermore,
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this study supports the superiority of LRS for fast characterization
of complex SVs. Massively parallel sequencing is currently
dominated by second-generation sequencing technology, mainly
relying on SRS, having its limitations for the identification of
cryptic SVs, sequencing repetitive regions, phasing of alleles, and
distinguishing highly homologous genomic regions, mainly due
to its short-read lengths. Third-generation or LRS technologies
offer improvements in the characterization of genetic variation
and regions that are difficult to assess with the current SRS
approaches. The main advantage of LRS compared to SRS
technologies comes from the use of long reads (>10 kb on
average), originating from single-DNA molecules. Apart from
this, the sequencing occurs in real time without the need
of PCR amplification, therefore being mostly free from PCR-
related bias. The power of LRS approaches to overcome specific
limitations of second generation–based analyses will further
become clear when LRS will be implemented in routine genetic
testing workflows.
Apart from the CEP78 SVs, the two novel splice variants
found here expand the spectrum of CEP78 (likely) pathogenic
SNVs: a novel canonical acceptor and donor splice variant of
intron 9, respectively, c.1209-2A>C (p.?), predicted to lead to
an exon 10 skip, and c.1208 + 2T > A (p.?), predicted to cause
an exon 9 skip. Interestingly, skipping of the 46-bp exon 10 was
previously reported for c.1254 + 5G>A (CEP78, NM_032171)
(Fu et al., 2016). When comparing the phenotypes found in
CRDHL cases with SNV and SVs, no apparent genotype–
phenotype correlation could be demonstrated that would allow
discriminating between the two classes of variants, emphasizing
the need for a systematic SV assessment in the genetic workup
of CRDHL cases, in which a CEP78 genotype is suspected or in
“atypical” Usher syndrome cases.
Using data mining of bulk or sc transcriptional datasets from
human retina, mouse cochlea, and human inner ear, we showed
expression in cone photoreceptors and in hair cell clusters. These
expression domains are in agreement with the main systems
affected in CRDHL, i.e., neural retina and the inner ear. Apart
from this, a correlation study of CEP78 expression strengthened
the importance of CEP78 in the ciliary machinery.
To conclude, this study supports that the CEP78 locus
is prone to microhomology-mediated, replication-based SV
formation and that (complex) SV analysis should be included
in molecular genetic testing of CRDHL or “atypical” Usher
syndrome. Finally, it demonstrates the power of WES-based CNV
assessment, sWGS, and whole or targeted LRS in identifying
and characterizing suspected complex SVs in patients with
CEP78-associated IRD. Systematic SV assessment in IRD will
certainly close a diagnostic gap and will contribute to precision
medicine in IRD.
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